AzTrials
AzTrials

BruxismNCT06824766

Chewing Muscles in Bruxers

An observational study of Bruxism, run by Bandırma Onyedi Eylül University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to determine the relationship between autonomic nervous system activity and tonus, stiffness and elasticity of temporalis and masseter muscles in individuals with bruxism and to compare them with healthy controls. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Bruxism
What is being tested?
Visual Analogue Scale, Autonomic nervous system activity assessment and Masticatory muscles assessment
How many people
89 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2025to 15 Oct 2025
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Bruxers

Who may be able to join

  • Diagnosed with bruxism between the ages of 18-65,
  • A history of bruxism for at least 6 months,
  • Individuals with masseter muscle pain ≥4 at rest and during mastication
  • Control group: Healthy individuals aged 18-65 years

Who cannot join

  • Masseter botox application in the last 6 months,
  • With regular use of analgesics and anti-inflammatories affecting the OSS,
  • Smokes 20 or more cigarettes daily,
  • With regular alcohol use of 1-2 glasses per day,
  • Daily coffee consumption of 6 cups or more,
  • Cardiovascular, respiratory and central nervous system diseases,
Show all 15Show fewer
  • Presence of infection or tumoural structures within intraoral structures,
  • Multiple ear piercings,
  • With TMJ disc displacement and joint degeneration,
  • Cervical or TMJ fracture, systemic disease, musculoskeletal problem with evidence of specific pathological condition,
  • Any surgical operation related to cervical or TMJ problem,
  • Less than 6 months of cervical or TMJ-related physiotherapy and rehabilitation services,
  • The one with facial paralysis,
  • Diagnosed psychiatric illness
  • Participants who have communication difficulties in speaking and understanding Turkish or who are unable to understand the exercises

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bandırma Onyedi Eylül University

    Balıkesir, Turkey, 10200

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Relationship Between Autonomic Nervous System Activity and Biomechanical Characteristics of Chewing Muscles in Bruxers

The aim of this study was to determine the relationship between autonomic nervous system activity and tonus, stiffness and elasticity of temporalis and masseter muscles in individuals with bruxism and to compare them with healthy controls.

Read the detailed description

Individuals diagnosed with bruxism and healthy individuals as a control group will be included in the study. Firstly, the purpose of the research and evaluation methods will be explained to the participants. Individuals who volunteer to participate in the study and meet the inclusion criteria will be included. Approval will be obtained from the individuals to be evaluated with the 'Informed Voluntary Consent Form'. Individuals will then fill in the Descriptive Data Form. The intensity of pain in the masticatory muscles of all participants at rest and during chewing will be measured by Visual Analogue Scale, Autonomic Nervous System activity (heart rate variables) will be measured by Polar H10 chest strap, and the tonus, stiffness and elasticity of the temporalis and masseter muscles will be measured by Myoton device. The evaluations are planned to take an average of 20 minutes for each participant. The evaluations of the participants will be made only once and will not be evaluated again.

Conditions
Bruxism
Being tested
Visual Analogue Scale, Autonomic nervous system activity assessment, Masticatory muscles assessment
Keywords
Autonomic nervous system, bruxism, masseter
Medical subject headings
Bruxism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Visual Analogue ScaleOther

    The pain intensity of the participants will be assessed using the Visual Analogue Scale, which is a simple, reliable and short-term method commonly used to measure pain intensity in the clinic. The participant is told that the most severe pain he/she experiences is 10 and if there is no pain, the pain intensity is 0. The participant will be asked to tick a number between 0 and 10 corresponding to the intensity of pain felt in the masticatory muscles at rest and during chewing.

  • Autonomic nervous system activity assessmentOther

    All participants included in the study will undergo a 5-minute test with the Polar H10 chest strap device for autonomic nervous system activity assessment (heart rate variability assessment). The data obtained after the measurement will be analysed with Kubios software. Stress index (cardiovascular system stress), PNS index (parasympathetic nervous system dominance), SNS index (sympathetic nervous system dominance), LF power (sympathetic activity), HF power (parasympathetic activity) and LF/HF ratio (sympathetic/parasympathetic balance) parameters will be used in the evaluation of HRV in Kubios programme.

  • Masticatory muscles assessmentOther

    The Myoton PRO device will be used to objectively assess the biomechanical properties of the participants' masticatory muscles such as tone, stiffness and elasticity. The masseter and temporalis muscles will be evaluated bilaterally in the sitting position. Three measurements will be recorded at one second intervals and the average value will be used for analysis.

Study groups in NCT06824766
Study groupRoleWhat they receive
BruxersIndividuals with bruxism
Receives: Other: Visual Analogue Scale; Other: Autonomic nervous system activity assessment; Other: Masticatory muscles assessment
Control groupHealthy volunteers
Receives: Other: Visual Analogue Scale; Other: Autonomic nervous system activity assessment; Other: Masticatory muscles assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale

    The pain intensity of the participants will be assessed using the Visual Analogue Scale, which is a simple, reliable and short-term method commonly used to measure pain intensity in the clinic. The participant is told that the most severe pain he/she experiences is 10 and if there is no pain, the pain intensity is 0. The participant will be asked to tick a number between 0 and 10 corresponding to the intensity of pain felt in the masticatory muscles at rest and during chewing.

    Measured: March 1, 2025- June 1, 2025

  2. Autonomic nervous system activity assessment

    All participants included in the study will undergo a 5-minute test with the Polar H10 chest strap device for autonomic nervous system activity assessment. The data obtained after the measurement will be analysed with Kubios software.

    Measured: March 1, 2025- June 1, 2025

  3. Masticatory muscles biomechanical properties assessment

    The Myoton PRO device will be used to objectively assess the biomechanical properties of the participants' masticatory muscles. The masticatory muscles will be evaluated bilaterally in the sitting position. Three measurements will be recorded at one second intervals and the average value will be used for analysis.

    Measured: March 1, 2025- June 1, 2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2025
  2. Study start1 Mar 2025
  3. Primary completion1 Oct 2025
  4. Study completion15 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
89 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06824766
Sponsor's protocol ID
2024-248
Status last verified
Feb 2025
First submitted
5 Feb 2025
Last updated
12 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Bruxism, run by Bandırma Onyedi Eylül University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale (time frame: March 1, 2025- June 1, 2025). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in